InvestorsHub Logo

bow-tie

03/01/21 10:41 AM

#23351 RE: Work Harder #23348

Looks like Prof. Volker Thiel from University of Bern has a good idea in fighting all the Covid Variants. MYMX in good hands at Bern!! Let's get it done MYMX!!

Prof. Volker Thiel, who heads the Department of Virology at the University of Bern, Switzerland, shared similar concerns. According to him: “Although the vaccines target only the spike gene, they should still mount an immune response that is diverse enough that these new variants should be covered.” He, however, emphasised that more experimental studies were needed.

Most of the COVID-19 vaccines elicit a high amount of antibodies that are able to target different regions of the spike protein and so, some of these antibodies could have the ability to target variants of the novel coronavirus.

At the same time, there research shows that the antibodies generated in the body against the virus are less effective in neutralising the 501Y.V2 variant. This is primarily due to the mutations in the spike protein in the new variant. Certain mutations render the new variant the ability to escape an antibody attack. However, as pointed out by Prof. Thiel, aside from antibodies, there are other elements in the immune system which can facilitate the fight against the mutant variants.

https://www.newsclick.in/COVID-19-Vaccines-Counter-Virus-Variants-Research-Mixed-Results

Our model system using yeast cells shows that it is ideally suited for reconstructing coronaviruses and other viruses
Volker Thiel
https://healthcare-in-europe.com/en/news/coronavirus-clone-produced-in-the-lab.html